Skip to main content

Table 2 Evaluation of basic biochemical parameters in patients with severe obesity and metabolic syndrome and in the control group

From: The short-term effect of bariatric surgery on non-invasive markers of artery function in patients with metabolic syndrome

 

OB1 (n = 40)

CG (n = 15)

p

Fasting glucose (mg/dl)a

89; 67–124

90; 81–102

NS

Fasting insulin (µIU/ml)a

14.07; 5.45–56.33

6.81; 3.57–12.73

<0.0001

HOMAa

3.31; 1.14–11.68

1.61; 0.78–3.02

<0.0001

Glucose level 2 h after OGTT (mg/dl)a

109.58 ± 31.16

95.27 ± 24.14

NS

Insulin level 2 h after OGTT (µIU/ml)a

46.53; 6.23–273.1

19.22; 7.21–52.56

0.001

HbA1C (%)a

5.65; 5.20–10.90

5.60; 5.30–5.80

0.001

Creatinine (mg/dl)b

0.76 ± 0.16

0.77 ± 0.08

NS

Total cholesterol (mg/dl)b

199.15 ± 35.13

184.07 ± 28.68

NS

HDL-chol (mg/dl)b

52.55 ± 10.97

69.53 ± 10.36

0.001

LDL-chol (mg/dl)b

120.30 ± 31.59

102.07 ± 25.32

0.04

Triglycerides (mg/dl)b

124.78 ± 47.70

63.80 ± 41.02

0.001

hsCRP (mg/l)b

10.19 ± 6.92

0.93 ± 0.76

NS

GFR (ml/min)b

96.14 ± 20.76

91.97 ± 16.19

NS

  1. aMedian; range
  2. bMean ± SD